Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia

AstraZeneca

Status: Completed

Conditions: Hypercholesterolaemia

Study type: Observational

Funder types: Industry

Identifiers

NCT01352897

NIS-CSG-CRE-2011/1

Details and patient eligibility

About

The objective of this follow-up retrospective study is to evaluate the long term efficacy and safety of rosuvastatin in reducing lipid parameters in clinical practice.

Enrollment: 800 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Primary hypercholesterolemia
• Subjects from first rosuvastatin Registry study